{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:19:20Z","timestamp":1775737160656,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1A2C1003483"],"award-info":[{"award-number":["NRF-2022R1A2C1003483"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21199-9","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:48:43Z","timestamp":1761295723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cold atmospheric plasma restores fulvestrant sensitivity by inhibiting CCND3 in the drug-resistant breast cancer cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Sooseong","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanghyun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeonjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyeon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjae","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hoon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Ha","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"21199_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10549-022-06572-w","volume":"193","author":"JA Mouabbi","year":"2022","unstructured":"Mouabbi, J. A. et al. Invasive lobular carcinoma: an understudied emergent subtype of breast cancer. Breast Cancer Res. Treat. 193, 253\u2013264. https:\/\/doi.org\/10.1007\/s10549-022-06572-w (2022).","journal-title":"Breast Cancer Res. Treat."},{"key":"21199_CR2","doi-asserted-by":"publisher","first-page":"8000","DOI":"10.1158\/1078-0432.Ccr-08-0975","volume":"14","author":"M Garcia-Closas","year":"2008","unstructured":"Garcia-Closas, M. & Chanock, S. Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin. Cancer Res. 14, 8000\u20138009. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-08-0975 (2008).","journal-title":"Clin. Cancer Res."},{"key":"21199_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks, A. G. & Winer, E. P. Breast cancer treatment: A review. Jama 321, 288\u2013300. https:\/\/doi.org\/10.1001\/jama.2018.19323 (2019).","journal-title":"Jama"},{"key":"21199_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/bf01833356","volume":"20","author":"A Manni","year":"1991","unstructured":"Manni, A., Wright, C. & Buck, H. Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar. Breast Cancer Res. Treat. 20, 43\u201352 https:\/\/doi.org\/10.1007\/bf01833356 (1991).","journal-title":"Breast Cancer Res. Treat."},{"key":"21199_CR5","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1158\/0008-5472.Can-22-3559","volume":"83","author":"B Li","year":"2023","unstructured":"Li, B. et al. Nanoparticle-based combination therapy enhances fulvestrant efficacy and overcomes tumor resistance in ER-positive breast cancer. Cancer Res. 83, 2924\u20132937. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-3559 (2023).","journal-title":"Cancer Res."},{"key":"21199_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1158\/0008-5472.Can-20-1601","volume":"81","author":"LS Crump","year":"2021","unstructured":"Crump, L. S. et al. Hormonal regulation of semaphorin 7a in ER(+) breast cancer drives therapeutic resistance. Cancer Res. 81, 187\u2013198. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-1601 (2021).","journal-title":"Cancer Res."},{"key":"21199_CR7","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/15548627.2019.1659609","volume":"16","author":"F Yang","year":"2020","unstructured":"Yang, F. et al. Stabilization of MORC2 by Estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to Estrogen-induced proliferation and endocrine resistance of breast cancer cells. Autophagy 16, 1061\u20131076. https:\/\/doi.org\/10.1080\/15548627.2019.1659609 (2020).","journal-title":"Autophagy"},{"key":"21199_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1158\/2159-8290.Cd-22-1387","volume":"14","author":"B Kingston","year":"2024","unstructured":"Kingston, B. et al. ESR1 F404 mutations and acquired resistance to fulvestrant in ESR1-mutant breast cancer. Cancer Discov. 14, 274\u2013289. https:\/\/doi.org\/10.1158\/2159-8290.Cd-22-1387 (2024).","journal-title":"Cancer Discov"},{"key":"21199_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41467-019-09068-2","volume":"10","author":"L Formisano","year":"2019","unstructured":"Formisano, L. et al. Aberrant FGFR signaling mediates resistance to CDK4\/6 inhibitors in ER\u2009+\u2009breast cancer. Nat. Commun. 10, 1373. https:\/\/doi.org\/10.1038\/s41467-019-09068-2 (2019).","journal-title":"Nat. Commun."},{"key":"21199_CR10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ccell.2018.10.014","volume":"34","author":"K Hinohara","year":"2018","unstructured":"Hinohara, K. et al. KDM5 histone demethylase activity links cellular transcriptomic heterogeneity to therapeutic resistance. Cancer Cell. 34, 939\u2013953e939. https:\/\/doi.org\/10.1016\/j.ccell.2018.10.014 (2018).","journal-title":"Cancer Cell."},{"key":"21199_CR11","doi-asserted-by":"publisher","unstructured":"Spoerke, J. M. et al. Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant. Nat. Commun. 7, 11579. https:\/\/doi.org\/10.1038\/ncomms11579 (2016).","DOI":"10.1038\/ncomms11579"},{"key":"21199_CR12","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1158\/0008-5472.can-03-3672","volume":"64","author":"S Akli","year":"2004","unstructured":"Akli, S. et al. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res. 64, 3198\u20133208. https:\/\/doi.org\/10.1158\/0008-5472.can-03-3672 (2004).","journal-title":"Cancer Res."},{"key":"21199_CR13","doi-asserted-by":"publisher","first-page":"216968","DOI":"10.1016\/j.canlet.2024.216968","volume":"593","author":"S Belli","year":"2024","unstructured":"Belli, S. et al. EGFR and HER2 hyper-activation mediates resistance to endocrine therapy and CDK4\/6 inhibitors in ER\u2009+\u2009breast cancer. Cancer Lett. 593, 216968. https:\/\/doi.org\/10.1016\/j.canlet.2024.216968 (2024).","journal-title":"Cancer Lett."},{"key":"21199_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10863-025-10061-2","volume":"57","author":"AB Zinnurova","year":"2025","unstructured":"Zinnurova, A. B. et al. Differences in metabolite profiling by cold atmospheric plasma in normal and cancer cells. J. Bioenerg Biomembr. 57, 97\u2013106. https:\/\/doi.org\/10.1007\/s10863-025-10061-2 (2025).","journal-title":"J. Bioenerg Biomembr."},{"key":"21199_CR15","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.3390\/molecules30132808","volume":"30","author":"Q Yang","year":"2025","unstructured":"Yang, Q. et al. The cold atmospheric plasma inhibits cancer proliferation through reducing glutathione synthesis. Molecules 30, 2808 https:\/\/doi.org\/10.3390\/molecules30132808 (2025).","journal-title":"Molecules"},{"key":"21199_CR16","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3390\/ijms26031093","volume":"26","author":"N Kitajima","year":"2025","unstructured":"Kitajima, N., Makihara, K. & Kurita, H. On the synergistic effects of cold atmospheric pressure plasma irradiation and electroporation on cytotoxicity of HeLa cells. Int. J. Mol. Sci. 26, 1093. https:\/\/doi.org\/10.3390\/ijms26031093 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"21199_CR17","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.3390\/cancers11122011","volume":"11","author":"S Park","year":"2019","unstructured":"Park, S. et al. Cold atmospheric plasma restores paclitaxel sensitivity to paclitaxel-resistant breast cancer cells by reversing expression of resistance-related genes. Cancers (Basel). 11, 2011 https:\/\/doi.org\/10.3390\/cancers11122011 (2019).","journal-title":"Cancers (Basel)"},{"key":"21199_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.freeradbiomed.2017.06.017","volume":"110","author":"S Lee","year":"2017","unstructured":"Lee, S. et al. Cold atmospheric plasma restores tamoxifen sensitivity in resistant MCF-7 breast cancer cell. Free Radic Biol. Med. 110, 280\u2013290. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.06.017 (2017).","journal-title":"Free Radic Biol. Med."},{"key":"21199_CR19","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3390\/cancers13081780","volume":"13","author":"P Shaw","year":"2021","unstructured":"Shaw, P., Kumar, N., Privat-Maldonado, A., Smits, E. & Bogaerts, A. Cold atmospheric plasma increases temozolomide sensitivity of three-dimensional glioblastoma spheroids via oxidative stress-mediated DNA damage. Cancers (Basel). 13, 1780 https:\/\/doi.org\/10.3390\/cancers13081780 (2021).","journal-title":"Cancers (Basel)"},{"key":"21199_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/biomedicines11010208","volume":"11","author":"D Murillo","year":"2023","unstructured":"Murillo, D., Huergo, C., Gallego, B. & Rodr\u00edguez, R. Exploring the use of cold atmospheric plasma to overcome drug resistance in cancer. Biomedicines 11, 208. https:\/\/doi.org\/10.3390\/biomedicines11010208 (2023).","journal-title":"Biomedicines"},{"key":"21199_CR21","doi-asserted-by":"publisher","first-page":"e2107220118","DOI":"10.1073\/pnas.2107220118","volume":"118","author":"B Guo","year":"2021","unstructured":"Guo, B. et al. Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance. Proc. Natl. Acad. Sci. U S A. 118, e2107220118. https:\/\/doi.org\/10.1073\/pnas.2107220118 (2021).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"21199_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/cbin.11939","volume":"47","author":"S Chupradit","year":"2023","unstructured":"Chupradit, S. et al. Recent advances in cold atmospheric plasma (CAP) for breast cancer therapy. Cell. Biol. Int. 47, 327\u2013340. https:\/\/doi.org\/10.1002\/cbin.11939 (2023).","journal-title":"Cell. Biol. Int."},{"key":"21199_CR23","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1158\/1078-0432.Ccr-23-2975","volume":"30","author":"C Guarducci","year":"2024","unstructured":"Guarducci, C. et al. Selective CDK7 inhibition suppresses cell cycle progression and MYC signaling while enhancing apoptosis in therapy-resistant estrogen receptor-positive breast cancer. Clin. Cancer Res. 30, 1889\u20131905. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-2975 (2024).","journal-title":"Clin. Cancer Res."},{"key":"21199_CR24","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3892\/mmr.2018.9064","volume":"7","author":"R Shen","year":"2015","unstructured":"Shen, R. et al. MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer. Am. J. Transl Res. 7, 2115\u20132126. https:\/\/doi.org\/10.3892\/mmr.2018.9064 (2015).","journal-title":"Am. J. Transl Res."},{"key":"21199_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1471-2407-6-224","volume":"6","author":"P Zhang","year":"2006","unstructured":"Zhang, P. et al. Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line. BMC Cancer. 6, 224. https:\/\/doi.org\/10.1186\/1471-2407-6-224 (2006).","journal-title":"BMC Cancer"},{"key":"21199_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.7150\/ijbs.100921","volume":"21","author":"Y Su","year":"2025","unstructured":"Su, Y. et al. Downregulated CCND3 is a key event driving lung adenocarcinoma metastasis during acquired cisplatin resistance. Int. J. Biol. Sci. 21, 708\u2013724. https:\/\/doi.org\/10.7150\/ijbs.100921 (2025).","journal-title":"Int. J. Biol. Sci."},{"key":"21199_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12032-024-02535-x","volume":"41","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Impaired cyclin D3 protein degradation contributes to trastuzumab resistance in HER2 positive breast cancer. Med. Oncol. 41, 305. https:\/\/doi.org\/10.1007\/s12032-024-02535-x (2024).","journal-title":"Med. Oncol."},{"key":"21199_CR28","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1158\/1078-0432.Ccr-20-3458","volume":"27","author":"CC Smith","year":"2021","unstructured":"Smith, C. C. et al. Recurrent mutations in cyclin D3 confer clinical resistance to FLT3 inhibitors in acute myeloid leukemia. Clin. Cancer Res. 27, 4003\u20134011. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-3458 (2021).","journal-title":"Clin. Cancer Res."},{"key":"21199_CR29","doi-asserted-by":"publisher","unstructured":"Yan, D. et al. Toward understanding the selective anticancer capacity of cold atmospheric plasma\u2013a model based on aquaporins (review). Biointerphases. 10, 040801. https:\/\/doi.org\/10.1116\/1.4938020 (2015).","DOI":"10.1116\/1.4938020"},{"key":"21199_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.biomaterials.2017.11.045","volume":"156","author":"JY Jang","year":"2018","unstructured":"Jang, J. Y. et al. Cold atmospheric plasma (CAP), a novel physicochemical source, induces neural differentiation through cross-talk between the specific RONS cascade and Trk\/Ras\/ERK signaling pathway. Biomaterials 156, 258\u2013273. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.11.045 (2018).","journal-title":"Biomaterials"},{"key":"21199_CR31","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/cas.15632","volume":"114","author":"N Deng","year":"2023","unstructured":"Deng, N., Zhang, X. & Zhang, Y. BAIAP2L1 accelerates breast cancer progression and chemoresistance by activating AKT signaling through binding with ribosomal protein L3. Cancer Sci. 114, 764\u2013780 https:\/\/doi.org\/10.1111\/cas.15632 (2023).","journal-title":"Cancer Sci."},{"key":"21199_CR32","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1038\/s41467-021-22638-7","volume":"12","author":"HB Low","year":"2021","unstructured":"Low, H. B. et al. DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death. Nat. Commun. 12, 2284. https:\/\/doi.org\/10.1038\/s41467-021-22638-7 (2021).","journal-title":"Nat. Commun."},{"key":"21199_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10911-022-09516-8","volume":"27","author":"M Valla","year":"2022","unstructured":"Valla, M., Kl\u00e6stad, E., Ytterhus, B. & Bofin, A. M. CCND1 amplification in breast cancer -associations with proliferation, histopathological grade, molecular subtype and prognosis. J. Mammary Gland Biol. Neoplasia. 27, 67\u201377. https:\/\/doi.org\/10.1007\/s10911-022-09516-8 (2022).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"21199_CR34","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3892\/or.9.6.1157","volume":"9","author":"H Fischer","year":"2002","unstructured":"Fischer, H., Chen, J., Skoog, L. & Lindblom, A. Cyclin D2 expression in familial and sporadic breast cancer. Oncol. Rep. 9, 1157\u20131161. https:\/\/doi.org\/10.3892\/or.9.6.1157 (2002).","journal-title":"Oncol. Rep."},{"key":"21199_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/a:1006103831990","volume":"52","author":"DM Barnes","year":"1998","unstructured":"Barnes, D. M. & Gillett, C. E. Cyclin D1 in breast cancer. Breast Cancer Res. Treat. 52, 1\u201315 https:\/\/doi.org\/10.1023\/a:1006103831990 (1998).","journal-title":"Breast Cancer Res. Treat."},{"key":"21199_CR36","doi-asserted-by":"publisher","first-page":"820","DOI":"10.4161\/cc.9.4.10783","volume":"9","author":"MR Gumina","year":"2010","unstructured":"Gumina, M. R., Xu, C. & Chiles, T. C. Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E. Cell. Cycle. 9, 820\u2013828. https:\/\/doi.org\/10.4161\/cc.9.4.10783 (2010).","journal-title":"Cell. Cycle"},{"key":"21199_CR37","doi-asserted-by":"publisher","unstructured":"Santamari\u00f1a, M., Hern\u00e1ndez, G. & Zalvide, J. CDK redundancy guarantees cell cycle progression in Rb-negative tumor cells independently of their p16 status. Cell Cycle. 7, 1962\u20131972. https:\/\/doi.org\/10.4161\/cc.7.13.6071 (2008).","DOI":"10.4161\/cc.7.13.6071"},{"key":"21199_CR38","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1038\/s41388-024-03117-x","volume":"43","author":"N Jirapongwattana","year":"2024","unstructured":"Jirapongwattana, N., Bunting, S. F., Ronning, D. R., Ghosal, G. & Karpf, A. R. RHNO1: at the crossroads of DNA replication stress, DNA repair, and cancer. Oncogene 43, 2613\u20132620. https:\/\/doi.org\/10.1038\/s41388-024-03117-x (2024).","journal-title":"Oncogene"},{"key":"21199_CR39","doi-asserted-by":"publisher","first-page":"109488","DOI":"10.1016\/j.cellsig.2019.109488","volume":"66","author":"KTP Nguyen","year":"2020","unstructured":"Nguyen, K. T. P. et al. CXCL12-CXCL4 heterodimerization prevents CXCL12-driven breast cancer cell migration. Cell. Signal. 66, 109488. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109488 (2020).","journal-title":"Cell. Signal."},{"key":"21199_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.freeradbiomed.2018.08.004","volume":"126","author":"S Lee","year":"2018","unstructured":"Lee, S. et al. ChIP-seq analysis reveals alteration of H3K4 trimethylation occupancy in cancer-related genes by cold atmospheric plasma. Free Radic Biol. Med. 126, 133\u2013141. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.08.004 (2018).","journal-title":"Free Radic Biol. Med."},{"key":"21199_CR41","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1158\/1078-0432.Ccr-15-1984","volume":"22","author":"CL Alves","year":"2016","unstructured":"Alves, C. L. et al. High CDK6 protects cells from fulvestrant-mediated apoptosis and is a predictor of resistance to fulvestrant in estrogen receptor-positive metastatic breast cancer. Clin. Cancer Res. 22, 5514\u20135526. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-1984 (2016).","journal-title":"Clin. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21199-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21199-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21199-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:48:44Z","timestamp":1761295724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21199-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21199"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21199-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37259"}}